List of Tuzistra Xr drug patents

Tuzistra Xr is owned by Aytu.

Tuzistra Xr contains Chlorpheniramine Polistirex; Codeine Polistirex.

Tuzistra Xr has a total of 2 drug patents out of which 0 drug patents have expired.

Tuzistra Xr was authorised for market use on 30 April, 2015.

Tuzistra Xr is available in suspension, extended release;oral dosage forms.

The generics of Tuzistra Xr are possible to be released after 29 March, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8790700 AYTU Modified release formulations containing drug-ion exchange resin complexes
Mar, 2027

(4 years from now)

US8062667 AYTU Modified release formulations containing drug-ion exchange resin complexes
Mar, 2029

(6 years from now)

Drugs and Companies using CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX ingredient

Market Authorisation Date: 30 April, 2015

Treatment: NA

Dosage: SUSPENSION, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in